A First for Oil & Gas: Clariant Opens Cutting-Edge High Throughput Experimentation Lab in Houston, US
A global boutique consultancy, we serve our clients in two ways: via client directed projects (TCG Consulting) and via various programs and studies (TCG Resources).

A First for Oil & Gas: Clariant Opens Cutting-Edge High Throughput Experimentation Lab in Houston, US

Clariant has opened its next High Throughput Experimentation (HTE) laboratory in Houston, Texas. The location is key as the new facility will be the first of its kind supporting the oil & gas industry, offering new and sophisticated solutions for customers. This lab is part of a global Clariant initiative to expand HTE capabilities to all Clariant business units, including direct support for oil services in North America, the Asia Pacific region, Latin America, Africa and the North Sea.HTE is an innovative approach and methodology where automated instrumentation, specialized software tools and alternative techniques are able to provide optimized formulations in a rapid timeframe. While it has been widely used in other industries for many years, Clariant is the first company to adopt this technology for the oil & gas industry as a standard tool.As a new addition to the existing lab located at Clariant Oil Services Headquarters, Clariant specialist chemists and innovation experts are now able to utilize miniaturization, parallelization, intelligent design and enhanced analytics – all proven to increase efficiency and productivity. The facility will help to meet current and outstanding needs in the oil & gas industry, with special emphasis on pour point depressants, hydrate inhibitors, asphaltene inhibitors, corrosion inhibitors and scale inhibitors. Source: Clariant, 9/6/2019.TCGR Note: High Throughput Experimentation (HTE) has of course been used as a tool by many process licensing and catalyst producers for years to optimize and create new generations of catalyst for a variety of processes within the oil, gas and chemicals industries. What is different, is Clariant’s announcement to apply this to specialty chemical development for inhibitors.